Cited by 17Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms

Open access
Schaffer, Leah V., Tucholski, Trisha, Shortreed, Michael R., Ge, Ying, Smith, Lloyd M.·2019·Analytical Chemistry

Abstract

Proteoforms, the primary effectors of biological processes, are the different forms of proteins that arise from molecular processing events such as alternative splicing and post-translational modifications. Heart diseases exhibit changes in proteoform levels, motivating the development of a deeper understanding of the heart proteoform landscape. Our recently developed two-dimensional top-down proteomics platform coupling serial size exclusion chromatography (sSEC) to reversed-phase chromatography (RPC) expanded coverage of the human heart proteome and allowed observation of high-molecular weight proteoforms. However, most of these observed proteoforms were not identified due to the difficulty in obtaining quality tandem mass spectrometry (MS2) fragmentation data for large proteoforms from complex biological mixtures on a chromatographic time scale. Herein, we sought to identify human heart proteoforms in this data set using an enhanced version of Proteoform Suite, which identifies proteoforms by intact mass alone. Specifically, we added a new feature to Proteoform Suite to determine candidate identifications for isotopically unresolved proteoforms larger than 50 kDa, enabling subsequent MS2 identification of important high-molecular weight human heart proteoforms such as lamin A (72 kDa) and trifunctional enzyme subunit α (79 kDa). With this new workflow for large proteoform identification, endogenous human cardiac myosin binding protein C (140 kDa) was identified for the first time. This study demonstrates the integration of our sSEC-RPC-MS proteomics platform with intact-mass analysis through Proteoform Suite to create a catalog of human heart proteoforms and facilitate the identification of large proteoforms in complex systems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.analchem.9b02343

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A recently developed 2DLC method coupling serial size-exclusion chromatography with reversed-phase chromatography enabled the detection and identification of larger heart proteins, including cMyBP-C and MHC, but required much larger amounts of tissue than the HCM septal myectomy tissues obtained.

    “Although we have recently developed a 2DLC method coupling serial size-exclusion chromatography with reversed-phase chromatography that enabled the detection and identification of larger heart proteins, including cMyBP-C and MHC (48, 49), it required much larger amount of tissues than the HCM septal myectomy tissues we obtained here.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schaffer, L. V., Tucholski, T., Shortreed, M. R., Ge, Y., & Smith, L. M.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
  • Ge, Ying
  • Smith, Lloyd M.
Venue
Analytical Chemistry
Published
2019-08-08
Volume
91
Issue
17
Pages
10937-10942
ISSN
  • 0003-2700 (ISSN-L)
  • 1520-6882
OpenAlex
W2967062596
Cited by
17
References
33
Citations by year
2026: 1 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 1
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Analytical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL096971, R01HL109810)
  • Office of the Director (S10OD018475)
  • National Institute of General Medical Sciences (R35GM126914, R01GM125085)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
proteoforms, high molecular weight proteins, myosin binding protein C, lamin A, protein identification, heart disease
MeSH terms
Myosin Binding Protein C, Amino Acid Sequence, Carrier Proteins, Chromatography, Gel, Humans, Myocardium, Protein Processing, Post-Translational, Software, Alternative Splicing, Proteome, Lamin Type A, Proteomics, Tandem Mass Spectrometry, Chromatography, Reverse-Phase, Mitochondrial Trifunctional Protein, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review